Sigal Charles Elliott
CIK 0001661908
Director
Filings
15
Latest May 28, 2026
Issuers covered
4
Showing
15 of 15
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 100% | +15.4% | +19.3% | +20.0% | +3.0% |
| 90 days | 4 | 25% | -1.7% | -7.0% | +14.8% | -7.5% |
| 180 days | 4 | 0% | -12.0% | -2.5% | -1.2% | -42.0% |
| 365 days | 4 | 0% | -57.3% | -59.4% | -50.3% | -60.0% |
Issuers
Companies where Sigal Charles Elliott has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | 8 | May 28, 2026 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 4 | May 22, 2026 |
| SURF | Surface Oncology, Inc. | 2 | Sep 8, 2023 |
| ADAP | Adaptimmune Therapeutics PLC | 1 | Jul 3, 2023 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|